A-C

Back to Index | D-K


  1. A Symposium of the Vitamins. Amer. Med. Assn., 1939.
  2. Abbasy, M. A., Harris. L. J. & Ellman. P. Lancet, 1937, p.181.
  3. Abbasy, M. A., Hill, N. J. and Harris, L. J.: Vitamin C and Juvenile Rheumatism. Lancet, 2: 1413, 1936.
  4. Abbasy, M. A. Biochem. J., London 31, 339(1937).
  5. Abbasy, M. A., Harris. L. J. & Hill, N. G. Lancet, 1937, p. 177.
  6. Abbott, W. E., Pilling, M. A., Griffin, C. E., Hirshfeld, J. W., and Mayer, F. L.: Biochem. J., 122: 678 (1945).
  7. Abbott, W. E.. and Hirshfeld, J. W.: Am. J. Surg. 74: 296 (Sept.) 1947.
  8. Abrams, E. and Sandson, J.: Ann. Rheum. Diseases, 27, 1964.
  9. Abramson, J. H., Slome, C., and Kosovsky, C. Food Frequency Interview as an Epidemiological Tool. American Journal of Public Health 53:7, 1093-1101, July 1963.
  10. Adams, C. F Nutritive Value of American Foods. Agriculture Handbook No. 456. 1975. Agricultural Research Service, United States Department of Agriculture. Washington, D.C. United States Government Printing Office.
  11. Afifi, A. M., Ellis, L., Huntsman, R. C., and Said, M. I. High Dose Ascorbic Acid in the Management of Thalassaemia Leg Ulcers-A Pilot Study. British Journal of Dermatology 92:3, 339-341, March 1975.
  12. Afroz, M., Bhothinard, B., Etzkorn, J. R., Horenstein, S., and McGarry, J. D. Vitamins C and B12. Journal of the American Medical Association 232:3, 246, 21 April 1975.
  13. Albrecht, E.: Vitamin C als Adjuvans in der Therapie der Lungentuberkulose. Med. Klin., 34: 972, 1938.
  14. Aldridge, H. Vitamin Megadoses Are Harmful, Either Insidiously or Dramatically, and Unnecessary, Physician Says. Arkansas Gazette, Little Rock, Arkansas, Thursday, 13 November 1975.
  15. Aleo, J. J. Inhibition of Endotoxin-Induced Depression of Cellular Proliferation by Ascorbic Acid. Proceedings of the Society for Experimental Biology and Medicine 164:3, 248-251, July 1980.
  16. Alleva, F. R., Alleva, J. J., and Balazs, T. Effect of Large Daily Doses of Ascorbic Acid on Pregnancy in Guinea Pigs, Rats and Hamsters. Toxicology and Applied Pharmacology 35:2, 393-395, February 1976.
  17. Allport, S. Long Term Toxic Effects from Clofibrate Reported. Medical News 4:20, 2, 8 December 1980.
  18. American Cancer Society. Cancer Facts and Figures, 1980. 777 Third Avenue, New York, N.Y. 10017.
  19. American Society Of Biological Chemists, Drug Topics, July 19, 1971.
  20. Anderson R. Vitamin C and immune functions: mechanisms of immunostimulation. In: Counsell, J. N., Hornig D H. eds. Vitamin C. London: Applied Science Publishers, 1981: 249-272.
  21. Anderson R., and Dittrich, O. C. Effects of Ascorbate on Leucocytes: Part IV. Increased Neutrophil Function and Clinical Improvement After Oral Ascorbate in Two Patients with Chronic Granulomatous Disease. South African Medical Journal 56:12, 476-480, 1 September 1979.
  22. Anderson, E: W. et al: Carbon monoxide linked to heart disease. J.A.M.A., 22:5, July 1972.
  23. Anderson, M.: Pro. Soc. Exptl. Biol. Med., 60, 12, 1945.
  24. Anderson, R., and Theron, A. Effects of Ascorbate on Leucocytes: Part III. In Vitro and In Vivo Stimulation of Abnormal Neutrophil Motility by Ascorbate. South African Medical Journal 56:11, 429-433, 8 September 1979.
  25. Anderson, R., Hay, I., Van Wyk, H., Oosthuizen, R., and Theron, A. The Effect of Ascorbate on Cellular Humoral Immunity in Asthmatic Children. South African Medical Journal 58:24, 974-977, 13 December 1980.
  26. Anderson, R., Oosthuizen, R., Maritz, R., Theron, A., and Van Rensburg, A. J. The Effects of Increasing Weekly Doses of Ascorbate on Certain Cellular and Humoral Immune Functions in Normal Volunteers. American Journal of Clinical Nutrition 33:1, 71-76, January 1980.
  27. Anderson, T. W. Vitamin C and the Common Cold. Journal of the Medical Society of New Jersey 76:11, 765-766, October 1979.
  28. Anderson, T. W. Vitamin C: Report of Trials with Massive Doses. In White, P. L., and Selvey, N., editors, Proceedings Western Hemisphere Nutrition Congress IV. Bal Harbour, Florida, 19-22 August 1974. Acton, Massachusetts, Publishing Sciences Group, Inc. Pp. 92-96.
  29. Andrus, W. D., and Barnes, W. A.: S. Clin. North America, 25, 350, 1945.
  30. Andrus, W. D.: Int. Abst. Surgery, 75, 161, 1942.
  31. Ann. Inst. Pasteur 56, 413 (1936)
  32. Antipenko, H. D., Hirurgija 9, 17 (1952).
  33. Arber, E., The Story of The Pilgrim Fathers. 1897.
  34. Archer, M. C., Tannenbaum, S. R., Tan, T.-Y., and Weisman, M. Reaction of Nitrite with Ascorbate and Its Relation to Nitrosamine Formation. Journal of the National Cancer Institute 54:4, 1203-1205, May 1975.
  35. Armstrong, B. K., Mann, J. I., Adelstein, A. M., and Eskin, F. Commodity Consumption and Ischemic Heart Disease Mortality with Special Reference to Dietary Practices. Journal of Chronic Diseases 28:9, 455-469, October 1975.
  36. Arthus: J. Pharm. Chem., 20: 41, 1919.
  37. Asahina and Asano: Prevention, July 1972. pp. 8 1-82.
  38. Ascorbic Acid Regimen May Reduce Calculus. Dental Times 11:12, 1 and 5, 1968.
  39. Aszodi, Biochem. Zeitschrift. 291. 1 (1937).
  40. Augustin, J. Variations in the Nutritional Composition of Fresh Potatoes. Journal of Food Science 40:6, 1295-1299, November/December 1975.
  41. Baird, I. M., Hughes, R. F., Wilson, H. K., Davies, J. E. W., and Howard, A. N. The Effects of Ascorbic Acid and Flavonoids on the Occurrence of Symptoms Normally Associated with the Common Cold. American Journal of Clinical Nutrition 32:8, 1686-1690, August 1979.
  42. Bakay, L: The Blood-Brain Barrier, C. Thomas, 1956.
  43. Baker, S. J., DeMeayer, E. M. Nutritional anemia: Its understanding and control with special reference to the work of the World Health Organisation. Am J Clin Nutr 1979; 32:368-417.
  44. Baker, A. B. & Noran, H. H.: Archives Int. Med. vol. 76, 146-153, 1945.
  45. Banajtisz, Sz. I., and M. M. Muszanov. Hirurgija 8,18 (1952).
  46. Banic, S. Prevention of Rabies by Vitamin C. Nature 258:5531, 153-154, 13 November 1975.
  47. Barac, G.: Recherches sur la brulure XL. Vassopressine, pituituine et effet diuretique de l'acide ascorbique chez le chien. Arch. internat. de pharmacodyn. et de thérap., 107:98. 1956.
  48. Barnes, R. N. and Martt, J. M., Sudden death syndrome, Texas Medicine, 71:49-57, October 1976.
  49. Barness, L. A. Safety Considerations with High Ascorbic Acid Dosage. Annals of the New York Academy of Sciences 258: Second Conference on Vitamin C, 523-527, 1975.
  50. Barrows, G. H., Burton, R. M., Jarrett, D. D., Russell, C. G., Alford, M. D., and Songster, C. L. Immunochemical Detection of Human Blood in Feces. American Journal of Clinical Pathology 69:3, 342- 346, March 1978.
  51. Barsum, G. S., and Gaddum, J. H.: Jr. Physiol., London, 85, 1, 1935.
  52. Bartlett, M., Jones, C. M., and Ryan, A. E. Vitamin C and Wound Healing. II. Ascorbic Acid Content and Tensile Strength of Healing Wounds in Human Beings. New England Journal of Medicine 226:12, 474-481, March 1942.
  53. Basu, T. K., Smethurst, M., Gillett, M. B., Donaldson, D., Jordan, S. J., Williams, D. C., and Hicklin, J. A. Ascorbic Acid Therapy for the Relief of Bone Pain in Paget’s Disease. Acta Vitaminologica et Enzymologica 32:1-4, 45-49, 1978.
  54. Baume, L. J.: Science News Letter, 64: 103, 1953.
  55. Bayer, Klin. Wschr. 1935, 301
  56. Beaton, G. H. Epidemiology of Iron Deficiency. In Jacobs, A., and Worwood, M. Iron in Biochemistry and Medicine. 1974. New York, Academic Press. Pp. 477-528.
  57. Becker, R. R., et al.: J. Am. Chem. Soc. 75: 2020, 195g.
  58. Beecher, H. K.: J.A.M.A. 124: 1193 (1944).
  59. Begin M E. Selective antineoplastic effects of polyunsaturated fatty acids. In: Kabara, J. J., ed. Pharmacological Effects of Lipids III. Champaign, Illinois: American Oil Chemists Society, 1989: 181-193.
  60. Behrman, R. E., Kliegman, R. M. Nelson text book of pediatrics. Philadelphia, Saunders 1987:1536-1558.
  61. Bejerot, N. Addiction: An Artificially Induced Drive. 1972. Springfield, Charles C. Thomas.
  62. Bell. G. H. Davidson. J. N. & Scarborough, H. Textbook Of Physiology And Biochemistry, 7th Edn, 1968, p. 249.
  63. Benade, L., Howard, T., Burk, D. Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1, 2, 4-triazole. Oncology 1969; 23: 33-43.
  64. Bender, A. E. The Fate of Vitamins in Food Processing Operations. In Stein, M. Vitamins. 1971. University of Nottingham Seminar. London, Churchill Livingstone.
  65. Berend-Fischer, Biochem. Zeitschrift. 291, 4(1937).
  66. Bergman, H. C. et al: Am. Heart J., vol. 29, 506-512, 1945.
  67. Berkeley, w. T., Jr.: Southern Med. J., vol. 58, pp. 1182-1184.
  68. Bersin, T., H. J. Lauber und H. Nafziger, Klin. Wschr. 16, 37, 1272 (1937).
  69. Bessey, O. A. and King, C. G.: The distribution of vitamin C in plant and animal tissues and its determination, J. Biol. Chem., 1933. 103: 687.
  70. Bietti, G. B. Further Contributions on the Value of Osmotic Substances as Means to Reduce Intra-ocular Pressure. Transactions of the Ophthalmological Society of Australia 26:61-71, 1967.
  71. Birkhang, K. E.: Tuberculosis in Animals Treated with Ascorbic Acid. J.A.M.A., 112: 2376, 1939.
  72. Blalock, A.: Surgery, 14, 487, 1943.
  73. Bodansky, O., Wroblewski, F., and Markardt, B. Concentrations of Ascorbic Acid in Plasma and White Cells of Patients with Cancer and Non-Cancerous Chronic Disease. Cancer Research 11:4, 238, April 1951.
  74. Bodian, D. and Horstmann, D., Review of their work. J.A.M.A. Aug 30th. 1952, vol. 149 #18.
  75. Bonham, G. S. Use Habits of Cigarettes, Coffee, Aspirin and Sleeping Pills, United States 1976. Vital and Health Statistics Series 10, Data from the National Health Survey: 131, DHEW publication (PHS) 80-1559.
  76. Bordet, J., and Gengou, O. Ann. Inst. Pasteur 20 (1906); 21 (1907).
  77. Bordia, A. The Effect of Vitamin C on Blood Lipids, Fibrinolytic Activity, and Platelet Adhesiveness in Patients with Coronary Artery Disease. Atherosclerosis 35:2, 181-187, February 1980.
  78. Bordia, A., Paliwal, D. K., Jam, K., and Kothari, L. K. Acute Effect of Ascorbic Acid on Fibrinolytic Activity. Atherosclerosis 30:4, 351-354, August 1978.
  79. Boring, C. C., Squires, T. S., Tong, T., Montgomery, S. Cancer statistics 1994. CA Cancer J Clin 1994; 44: 7-26.
  80. Borsalino, G.: La Fragile Caillare Nella Tuberculose Polmonare a le sue Modificazione par Azione Della Vitamin C. Gior. di clin. med., 18: 273, 1937.
  81. Borsook, H. et al: J. Biol. Chem., 117:237, 1937.
  82. Bouhuys, A. Colds and Antihistaminic Effects of Vitamin C. New England Journal of Medicine 290:1, 633, 14 March 1974.
  83. Boukhris, R., Khaznaji, M., Akef, N., and BeuAyed, H. Lipemia, Uricemia, and Vitamin C. Tunisie Medicale 51:1, 25-29, January-February 1973.
  84. Bourne, G. H. The Effect of Vitamin C on the Healing of Wounds. Proceedings of the Nutrition Society 4:3-4, 204-216, 1946.
  85. Boxer, L. A., Vanderbilt, B., Bonsib, S., Jersild, R., Yang, H. H., and Baehner, R. L. Enhancement of Chemotactic Response and Microtubule Assembly in Human Leukocytes by Ascorbic Acid. Journal of Cellular Physiology 100:1, 119-126, July 1979.
  86. Boyd, T. A. Campbell, F. W.: B. Med. J., 2: 1145, Nov. 1950.
  87. Bradford, W. L. et al: The Influence of adrenal cortex extract on the resistance to certain infections and intoxication. Endocrinology, 17:529, 1933.
  88. Bram S, Froussard P et al. Vitamin C preferential toxicity for malignant melanoma cells. Nature 1980; 284: 629 - 631.
  89. Bram, S., Froussard, P., Guichard, M., Jasmin, C., Augery, Y., Sinoussi-Barre, F, and Wray, W. Vitamin C. Preferential Toxicity for Malignant Melanoma Cells. Nature 284:5757, 629-631, 17 April 1980.
  90. Brandt, R., Colyer, K. E., and Banks, W. C., Jr. A Simple Method to Prevent Vitamin C Interference with Urinary Glucose Determinations. Clinica Chemica Acta 51:1, 103-104, 28 February 1974.
  91. Bray. W. E. Clinical Laboratory Methods. 1957, Pp. 108 & 351.
  92. Briggs, M. H. Effects of Vitamin C on Bilirubin. Medical Journal of Australia 2:14, 542-543, 5 October 1974.
  93. Briggs, M. H. Fertility and High-Dose Vitamin C. Lancet 2:7837, 1083, 10 November 1973.
  94. Briggs, M. H. More Vitamin C. Medical Journal of Australia 1:18, 722-723, 4 May 1974.
  95. Briggs, M. H. Side-Effects of Vitamin C. Lancet 2:7843, 1439, 22 December 1973.
  96. Briggs, M. H. Vitamin C and Infertility. Lancet 2:7830, 677-678, 22 September 1973.
  97. Briggs, M. H. Vitamin C in the Buffy Coat in Leukemia. Medical Journal Australia 1:5, 152, 2 February 1974.
  98. Briggs, M. H., and Johnson, J. Dangers of Excess Vitamin C. Medical Journal of Australia 2:1, 48-49, 7 July 1973.
  99. Briggs, M. H., Garcia-Webb, P., and Davies, P Urinary Oxalate and Vitamin C Supplements. Lancet 2:7822, 201, 28 July 1973.
  100. Briggs, M., and Briggs, M. Vitamin C Requirements and Oral Contraceptives. Nature 238:5362, 277, 4 August 1972.
  101. Brim, M. Example of Behavioral Changes in Marginal Vitamin Deficiency in the Rat and Man. In Brozek, Josef, editor. Behavioral Effects of Energy and Protein Deficits. Proceedings International Nutrition Conference, NIH Publication 79-1906, August 1979.
  102. Bring, S. V., and Raab, F. P. Total Ascorbic Acid in Potatoes. Journal of the American Dietetic Association 45:2, 149-152, August 1964.
  103. Bring, S. V, Grassl, C., Hofstrand, J. T., and Willard, M. J. Total Ascorbic Acid in Potatoes. Journal of the American Dietetic Association 42:4, 320-324, April 1963.
  104. Brody, H. D.: J. Amer. Diet. Ass., 29:588, 1953.
  105. Bronte-Stewart, B., Roberts, B., and Wells, V. M. Serum Cholesterol in Vitamin C Deficiency in Man. British Journal of Nutrition 17:1, 61- 68, 1963.
  106. Brown, H. H.: Whooping cough, Clin. J., 1936. 65: 246.
  107. Burch, H. B. Methods for Detecting and Evaluating Ascorbic Acid Deficiency in Man and Animals. Annals of the New York Academy of Sciences 92:1, 268-276, 21 April 1961.
  108. Burns, J. J. Am. J. Med. 26: 740, 1959
  109. Burns, J. J. et al.: J. Biol. Chem. 207: 679, 1954.
  110. Burr, R. G., and Rajan, K. T. Leucocyte Ascorbic Acid and Pressure Sores in Paraplegia. British Journal of Nutrition 28:2, 275-281, September 1972.
  111. Butterworth, C. E., Jr. Nutrition Assessment of Ambulatory Patients. Vitamin Nutrition Issues. 1979. Nutley, New Jersey, Hoffman-La Roche. Pp. 25-28.
  112. Butler, S. and Thomas, W. A.: "Intravenous Histamine in the Treatment of Migraine. Preliminary Observations", The Journal of the American Medical Association. Volume CXXVIII, 1945, page 173.
  113. Cain, R. F. Technology of Fortification of Foods. Paper presented at a workshop sponsored by the Food Protection Committee, National Academy of Sciences, 1975.
  114. Cameron E, Campbell A, Jack T. The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol interact 1975; 11: 387-393.
  115. Cameron E, Campbell A. Innovation vs quality control: an ‘unpublishable’ clinical trial of supplemental ascorbate in incurable cancer. Med Hypotheses 1991; 36: 185 - 189.
  116. Cameron E, Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 1974; 9: 285-315.
  117. Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res 1979; 39: 663-681.
  118. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1976; 73: 3685 - 89.
  119. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci. USA 1978; 75: 4538-4542.
  120. Cameron E, Pauling L. The orthomolecular treatment of cancer. I. The role of ascorbate in host resistance. Chem Biol Interact 1974; 9: 273 - 283.
  121. Cameron E. Protocol for the use of vitamin C in the treatment of cancer. Med Hypotheses 1991; 36: 190-194.
  122. Cameron E. Vitamin C for cancer (letter). N Engl J Med 1980; 302: 299.
  123. Cameron, E., and Baird, G. M. Ascorbic Acid and Dependence on Opiates in Patients with Advanced and Disseminated Cancer. Journal of International Research Communications 1:6, 38, August 1973.
  124. Cameron, E., and Campbell, A. The Orthomolecular Treatment of Cancer. II. Clinical Trial of High-Dose Ascorbic Acid in Advanced Human Cancer. Chemical-Biological Interactions 9:4, 285-315, October 1974.
  125. Cameron, E., and Jack, T. The Orthomolecular Treatment of Cancer. III. Reticulum Cell Sarcoma: Double Complete Regression Induced by High Dose Ascorbic Acid Therapy. Chemical-Biological Interactions 11:5, 387-393, November 1975.
  126. Cameron, E., and Leibovitz, B. Ascorbic Acid and Cancer: A Review. Cancer Research 39:3, 663-681, March 1979.
  127. Cameron, E., and Pauling, L. Ascorbic Acid and the Glycosaminoglycans: An Orthomolecular Approach to Cancer and Other Diseases. Oncology 27:2, 181-192, 1973.
  128. Cameron, E., and Pauling, L. Cancer and Vitamin C. 1979. New York, W. W. Norton. P 106.
  129. Cameron, E., and Pauling, L. Prolongation of Survival Times in Terminal Human Cancer. Proceedings of the National Academy of Sciences 73:10, 3685-3689, October 1976.
  130. Cameron, E., and Pauling, L. Supplemental Ascorbate in the Supportive Treatment of Cancer: Reevaluation of Prolongation of Survival Times in Terminal Human Cancer. Proceedings of the National Academy of Sciences 75:9, 4538-4542, September 1978.
  131. Cameron, E., and Pauling, L. The Orthomolecular Treatment of Cancer. I. The Role of Ascorbic Acid in Host Resistance. Chemical-Biological Interactions 9:4, 273- 283, October 1974.
  132. Cameron, E., and Rotman, D. Ascorbic Acid, Cell Proliferation, and Cancer. Lancet 1:749, 542, 4 March 1972.
  133. Campbell A, Jack T. Acute reactions to mega ascorbic acid therapy in malignant disease. Scot Med J 1979; 24: 151.
  134. Campbell, A. M. G. et al: Significant brain damage caused by smoking marijuana. Lancet, Dec. 1971.
  135. Campbell, C. D., Jr., Steinberg, M. H., and Bower, J. D. Ascorbic Acid-Induced Hemolysis in G-6-PD Deficiency. Annals of Internal Medicine 82:6, 810, June 1975.
  136. Cannon, W. B. The Wisdom of the Body. 1932. New York, W. W. Norton.
  137. Capps, B. B.: Modern Med., Jan. 11, 1971.
  138. Carrel, Alexis: Man the Unknown. p. 207, 1935.
  139. Carswell E A, Old L J, Kassel R L, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-3670.
  140. Cathcart R F. Vitamin C: the nontoxic, nonrate-limited, antioxidant free radical scavenger. Med Hypotheses 1985; 18: 61-77.
  141. Cathcart, R. F, III. The Method of Determining Proper Doses of Vitamin C for the Treatment of Disease by Titrating to Bowel Tolerance. Journal of Orthomolecular Psychiatry 10:2, 125-132, March-April 1981.
  142. Cell Organelle Defects Again Associated with Genetic Disease. Journal of the American Medical Association 238:6, 461-462, 8 August 1977.
  143. Chakrabarti R N, Dasgupta P S. Effects of ascorbic acid on survival and cell-mediated immunity in tumor bearing mice. IRCS Med Sci 1984; 12: 1147 - 1148.
  144. Chalmers AH, CowIey DM, Brave JM. A possible etiological role for ascorbate in calculi formation. Clin Chem 1986;32:333-336.
  145. Chalmers, F. W., Clayton, M. M., Gates, L. O., Tucker, R. F., Wertz, A. W., Young, C. M., and Foster, W. D. The Dietary Record-How Many and Which Days? Journal of the American Dietetic Association 28:8, 711-717, August 1952.
  146. Chambers, R. and Pollock, H.: J. Gen. Physiol., 10:739, 1927.
  147. Chambers, R. et al: Physiol. Rev., vol. 27, 436-463, 1947.
  148. Chatterjee, I. B., Kar, N. C., Guha, B. C.: N.Y. Acad. Science 92:36, 1961.
  149. Cheraskin, E. The Ecology of Periodontal Disease. Report Proceedings. Workshop on Diet, Nutrition and Periodontal Disease, American Society of Preventive Dentistry, Sun Valley, Idaho, 7-27, 4-7 August 1974.
  150. Cheraskin, E., and Ringsdorf, W. M., Jr. A Lingual Vitamin C Test: XIV. Relationship to Oral Calculus. International Journal for Vitamin Research 38:5, 531-537, 1968.
  151. Cheraskin, E., and Ringsdorf, W. M., Jr. Another Look at the "Ideal" Serum Cholesterol Level? Archives of Internal Medicine 140:4, 580- 581, April 1980.
  152. Cheraskin, E., and Ringsdorf, W. M., Jr. Biology of the Orthodontic Patient. III. Relationship of Chronologic and Dental Age in Terms of Vitamin C State. Angle Orthodontist 42:1, 56-59, January 1972.
  153. Cheraskin, E., and Ringsdorf, W. M., Jr. Biology of the Orthodontic Patient: I. Plasma Ascorbic Acid Levels. Angle Orthodontist 39:2, 137-138, April 1969.
  154. Cheraskin, E., and Ringsdorf, W. M., Jr. Biology of the Orthodontic Patient: II. Lingual Vitamin C Test Scores. Angle Orthodontist 39:4, 324-325, October 1969.
  155. Cheraskin, E., and Ringsdorf, W. M., Jr. New Hope for Incurable Diseases. 1971. Jericho, New York, Exposition Press.
  156. Cheraskin, E., and Ringsdorf, W. M., Jr. The Mental Illness Proneness Profile. Alabama Journal of Medical Science 10:1, 32-45, January 1973.
  157. Cheraskin, E., and Ringsdorf, W. M., Jr. Vitamin C and Chronologic Versus Bone Age. Journal of Oral Medicine 28:3, 77-80, July/September 1973.
  158. Cheraskin, E., and Ringsdorf, W. M., Jr. Vitamin C State in a Dental School Patient Population. Journal of the Southern California State Dental Association 32:10, 375-378, October 1964.
  159. Cheraskin, E., Ringsdorf, W. M., Jr. and Hicks, B. S. Daily Vitamin C Consumption and Reported Cardiovascular Findings. Journal of the International Academy of Preventive Medicine 1:1, 31-44, Spring 1974.
  160. Cheraskin, E., Ringsdorf, W. M., Jr., and Medford, F. H. Daily Vitamin C Consumption and Fatigability. Journal of the American Geriatrics Society 24:3, 136-137, March 1976.
  161. Cheraskin, E., Ringsdorf, W. M., Jr., and Medford, F. H. The "Ideal" Daily Vitamin C Intake. Journal of the Medical Association of the State of Alabama 46:12, 39-40, June 1977.
  162. Cheraskin, E., Ringsdorf, W. M., Jr., and Medford, F. H. Tissue Tolerance to Orthodontic Banding: Two Studies in Multivitamin-Trace Mineral Versus Placebo Supplementation. International Journal of Orthodontics 17:4, 6-20, December 1979.
  163. Cheraskin, E., Ringsdorf, W. M., Jr., Aspray, D. W., and Preskitt, D. A Lingual Vitamin C Test: XIII. Relationship to Oral Hygiene. International Journal for Vitamin Research 38:5, 524-530, 1968.
  164. Cheraskin, E., Ringsdorf, W. M., Jr., Medford, F H., and Hicks, B. S. Relationship of Vitamin C and Skin Symptoms and Signs. Journal of the Canadian Chiropractic Association 22:3, 97-98, October 1978.
  165. Cheraskin, E., Ringsdorf, W. M., Jr., Medford, F H., and Hicks, B. S. The Relationship of Vitamin C Intake and the Total White Cell Count. Nutritional Perspectives 1:2, 34-36, April 1978.
  166. Cheraskin, E., Ringsdorf, W. M., Jr., Michael, D. W., and Hicks, B. S. Daily Vitamin C Consumption and Reported Respiratory Findings. International Journal for Vitamin and Nutrition Research 43:1, 42- 55, 1973.
  167. Cheraskin, E., Strother, E. W., and Speed, E. M. What Is Pyorrhea? General Practice 11:3, 69-73, March 1955.
  168. Cheraskin, E.. Ringsdorf, W. M. & El-Ashiry. G. A Lingual Vitamin C Test. International Journal For Vitamin And Nutrition Research. 1963—64. p. 34.
  169. Cheraskin, F., and Ringsdorf, W. M., Jr. (with Brecher, A.) Psychodietetics. 1976. New York, Bantam Books. Pp. 155-194. (Originally published by Stein and Day)
  170. Cheraskin, F., and Ringsdorf, W. M., Jr. A Lingual Vitamin C Test: VII. Relationship of Nonfasting Serum Cholesterol and Vitamin C State. International Journal for Vitamin Research 38:3/4, 415-420, 1968.
  171. Cheraskin, F., and Ringsdorf, W. M., Jr. A Lingual Vitamin C Test: XIX. Normal versus Physiologic Range. Journal of the Ontario Dental Association 47:10, 239-241, October 1970.
  172. Cheraskin, F., and Ringsdorf, W. M., Jr., and Clark, J. W. Diet and Disease. 1968. Emmaus, Pennsylvania, Rodale Books. Pp. 65-84.
  173. Cheraskin, F., Ringsdorf, W. M., Jr., and Clark, J. W. Diet and Disease. 1977. New Canaan, Conn., Keats Publishing, Inc.
  174. Cheraskin, F., Ringsdorf, W. M., Jr., Hicks, B. S., and Romano, D. M. The Prevention of Oral Disease. Journal of the International Academy of Preventive Medicine 2:1, 22-52, First Quarter 1975.
  175. Cheraskin, F., Ringsdorf, W. M., Jr., Michael, D. W., and Hicks, B. S.
  176. Chisholm, T.C. and Hardenbergh, E.: Ann. Surg. 127:75 (Jan.) 1948.
  177. Christakis, G. Nutritional Assessment in Health Programs. American Journal of Public Health 63: Supplement 1, 11-18, November 1973.
  178. Church, C. F. Bowes and Church Food Values of Portions Commonly Used. 1966. Tenth Edition. Philadelphia, J. B. Lippincott.
  179. Churchill, D., Bryant, D. Fodor, G., and Gault, M. H. Drinking Water Hardness and Urolithiasis. Annals of Internal Medicine 88:4, 513- 514, April 1978.
  180. Cilento, P. Medical Journal Of Australia. August 25, 1973, p. 408.
  181. Citrus Sappers-Heat and Oxygen. Science News 117:13, 201, 29 March 1980.
  182. Clark, E.J. and Rossiter, R.J.: Quart. J. Exper. Physiol. 32: 279 (1944).
  183. Clark, J. W., Cheraskin, E., and Ringsdorf, W. M., Jr. An Ecologic Study of Oral Hygiene. Journal of Periodontology-Periodontics 40:8, 476- 480, August 1969.
  184. Clark, J. W., Cheraskin, E., and Ringsdorf, W. M., Jr. Diet and the Periodontal Patient. 1970. Springfield, Charles C. Thomas.
  185. Clayson, D. E. Nutrition and Experimental Carcinogenesis: A Review. Paper presented at the Conference on Nutrition in the Causation of Cancer. Key Biscayne, Fla., May 1975.
  186. Clemetson, C. A. B. Some Thoughts on the Epidemiology of Cardiovascular Disease (With Special Reference to Women "On the Pill"), Role of Ascorbic Acid. Medical Hypotheses 5:8, 825-834, August 1979.
  187. Clemmesen, C.: Bisperbjerg Hospital, Copenhagen, Mod. Med., 123-124, July, 1954.
  188. Cohen M H, Krasnow S H. Cure of advanced Lewis lung carcinoma (LL): a new treatment strategy. Proceedings of AACR 1987; 28: 416.
  189. Cohen, D. W., Friedman, L. A., Shapiro, J., Kyle, G. C., and Franklin, S. Diabetes Mellitus and Periodontal Disease: Two-Year Longitudinal Observations. Part I. Journal of Periodontology 41:12, 709-712, December 1970.
  190. Collins, C. K., Lewis, A. E., Ringsdorf, W. M., Jr., and Cheraskin, E. Effect of Ascorbic Acid on Oral Healing in Guinea Pigs. International Journal of Vitamin Research 37:4, 492-495, 1967.
  191. Colwell, J. A., and Lizarralde, C. Diabetes and Metabolic Disorders: Continuing Education Review. 1975. Flushing, New York, Medical Examination Publishing Company.
  192. Committee on Dietary Allowances. Food and Nutrition Board. Recommended Dietary Allowances. Ninth Revised Edition, 1980. Washington, D.C., National Academy of Sciences.
  193. Conn, R. Too Many Vitamins? (Vitamin C and Iron Absorption). Wichita Eagle, Wednesday, 9 July 1980.
  194. Conney, A. H., et al.: N.Y. Aced. Science 92: 115, 1961.
  195. Cook, J. D., and Monsen, E. R. Vitamin C, the Common Cold, and Iron Absorption. American Journal of Clinical Nutrition 30:2, 235-241, February 1977.
  196. Cook. J. D., Finch, C. A., and Smith, N. J. Evaluation of Iron Status of a Population. Blood 48:3, 449-455, September 1976.
  197. Cooke, W. L., and Milligan, R. S. Recurrent Hemoperitoneum Reversed by Ascorbic Acid. Journal of the American Medical Association 237: 13, 1358-1359, 28 March 1977.
  198. Corbetti, B. Big Doses of Vitamin C Branded More Harm Than Help. San Diego Evening Tribune, 7 December 1974.
  199. Corkery, E., Collinson, A. H. & Dettmann, G. C. Aboriginal Infant Mortality And Vitamin C Relationship. 197 1—72. In Press.
  200. Cormia, F E.: Experimental arsphenamine dermatitis, influence of vitamin C in production of arsphenamine sensitiveness. Canad. M. A.J., 36 :392, 1937.
  201. Corren, A. E.: Vitamin C content of human and cow milk in summer. Klin. Wchnschr., 1937. 16: 81.
  202. Cosentino, G.: Acido ascorbico ed ormone corticosurrenale nel trattamento locale dl peritoniti acute sperimentali. Gior. di batteriol. e immunol. 23:531, 1939.
  203. Cotlier, E., and Duwelius, A. Effect of Ascorbic Acid on Hexosaminidase Activity. New England Journal of Medicine 285:7, 409, 12 August 1971.
  204. Coulehan, J. L. Ascorbic Acid and the Common Cold. Postgraduate Medicine 66:3, 153-155, 157-158, 160, September 1979.
  205. Cousins, N. Anatomy of an Illness (as Perceived by the Patient). New England Journal of Medicine 295:26, 1458-1463, 23 December 1976.
  206. Cousins, N. Anatomy of an Illness. 1979. New York, W. W. Norton.
  207. Cowan, A. The Influence of Vitamin C on the Periodontal Membrane Space-A Radiographic Study. Irish Journal of Medical Science 145:9, 273-284, September 1976.
  208. Cox, B. D., Whichelow, M. J., Butterfield, W. J. H., and Nicholas, P. Peripheral Vitamin C Metabolism in Diabetics and Non-Diabetics: Effect of Intra-Arterial Insulin. Clinical Science & Molecular Medicine 47:1, 63-72, July 1974.
  209. Cox, E. V. The Anemia of Scurvy. In Harris, R. S., Wool, I. G., and Loraine, J. A. Vitamins and Hormones. Volume 26. 1968. New York, Academic Press. Pp. 635-652.
  210. Crandon, J. H.; Lund, C. C.; Dill, D. B., Experimental Human Scurvy. N. Eng. J. of Med. 223:353, 1940.
  211. Creagan, E. T., Moertel, C. G., O'Fallon, J. R., Schutt, A. J., O'Connell, M. J., Rubin, J., and Frytak, S. Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer: A Controlled Trial. New England Journal of Medicine 301:13, 687-690, 27 September 1979.
  212. Current Concepts of Pneumonia. Scope, Jan., 1945.

© November, 2013   AscorbateWeb